AstraZeneca Stock Leads 3 Blue Chips Trading Below Fair Value

With energy prices, inflation signals and central bank decisions all pulling markets in different directions, many investors are looking for stocks where the cash flows tell a clearer story than the headlines. The Undervalued Stocks Based On Cash Flows screener focuses on companies that SWS DCF valuation suggests are trading below their estimated fair value, based on their cash flow potential. For investors who care about what a business generates in cash rather than short term sentiment, this can be a useful starting point. This article highlights 3 of the most interesting stocks from that screener today.

AstraZeneca (LSE:AZN)

Overview: AstraZeneca is a large biopharmaceutical company that discovers, develops, manufactures and sells prescription medicines across oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines and rare diseases, serving doctors and patients worldwide.

Operations: AstraZeneca generates its revenue primarily from pharmaceuticals, with about US$60.4b coming from this segment.

Market Cap: £196.5b

Investors looking at cash flow backed opportunities may find AstraZeneca interesting because it combines a broad late stage drug pipeline and active emerging market presence with high forecast returns on equity and what the SWS DCF model suggests is a large gap between price and estimated value. At the same time, heavy reliance on blockbuster therapies and exposure to tighter drug pricing and biosimilar competition create meaningful risk if new launches or R&D productivity do not keep pace. The recent run of oncology approvals and label expansions shows how much is already in motion for AstraZeneca, but it also raises the stakes for what comes next in its pipeline and capital allocation story.

AstraZeneca’s cash flow story and late stage pipeline could be telling investors something the share price has not fully reflected yet, and the DCF valuation analysis for AstraZeneca may reveal how that gap ties into the biggest risk in its pipeline and capital allocation story.

Foresight Group Holdings (LSE:FSG)

Overview: Foresight Group Holdings is an asset manager that focuses on infrastructure, renewable energy and private equity, raising and managing funds for institutional and retail investors across the UK, Europe and Australia.

Operations: Foresight Group Holdings generates most of its revenue from Real Assets at about £114.8m, with Private Equity contributing around £50.1m, and the bulk of its income coming from the United Kingdom at about £126.4m, followed by Australia at roughly £25.7m.

Market Cap: £525.3m

Foresight Group Holdings is attracting attention from cash flow focused investors because it blends strong earnings quality with visible levers for growth in fee based revenue, backed by rising assets in renewable infrastructure and private equity. The stock trades below some fair value estimates. Analysts see room for higher earnings, supported by a P/E that sits close to the UK capital markets average and an active buyback that is already reducing voting share count. At the same time, heavy exposure to UK and European policy on renewables, reliance on performance fees and a funding mix built on external borrowings mean profitability could come under pressure if fundraising or investment performance cools. This is what investors will want to weigh against the current valuation and buyback story.

Foresight Group Holdings looks like an earnings machine hiding in plain sight, with fee based growth and buybacks reshaping the equity story. See how the analysis report for Foresight Group Holdings frames the one factor that could change the script.

BAE Systems (LSE:BA.)

Overview: BAE Systems is a global defense and aerospace company that supplies combat aircraft, warships, munitions, electronic warfare systems, space electronics and cyber security solutions to governments and defense customers worldwide.

Operations: BAE Systems generates its revenue across Electronic Systems (£7.5b), Air (£7.4b), Maritime (£6.6b), Platforms & Services (£5.0b), and Cyber & Intelligence (£2.4b), with a small Head Quarter contribution and intra group eliminations.

Market Cap: £55.8b

BAE Systems is worth a closer look if you want exposure to defense cash flows, because it combines a £75b order backlog and double digit forecast earnings growth with a share price that sits below some estimated cash flow based fair values. A broad pipeline in drones, electronic warfare and uncrewed systems, backed by fresh contracts from the US, UK and allies, gives the business multi year revenue visibility. At the same time, its current P/E is below the wider European Aerospace & Defense average. Set against that, heavy reliance on large government contracts, supply chain constraints and a capital structure funded entirely by external borrowing mean investors are taking on real risk around margins and resilience, which the detailed analysis brings into sharper focus.

BAE Systems’ order book and earnings outlook hint at a story the share price may not fully capture yet. The analyst forecasts for BAE Systems could highlight the contract risk or margin twist investors are missing.

The 3 stocks covered here are just a starting point. The full Undervalued Stocks Based On Cash Flows screener surfaces 40 more companies where the cash flow story and valuation gap could be just as compelling as anything you have seen so far in the Undervalued Stocks Based On Cash Flows screener. Use Simply Wall St to identify and analyze the specific catalysts, cash flow profiles and valuation narratives that matter to you so you can focus on the highest conviction ideas for your watchlist.

Take Control of Your Investment Journey

If Foresight Group Holdings or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives With Real Potential?

New ideas often move first when momentum is building, breakouts are forming and prices have not yet surged. Review these fresh picks before they become widely followed.

• Spot early strength in smaller companies before headlines catch up by reviewing the 47 elite penny stocks with strong financials that currently pass strict financial quality filters.
• Explore the next wave of intelligent automation by scanning the 34 robotics and automation stocks featuring businesses tied to factories, logistics and real world robotics demand.
• Monitor potential demand shifts by checking the 33 elite gold producer stocks focused on producers with meaningful exposure to gold production and precious metals trends.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com